Download PDF
Semin intervent Radiol 2011; 28(2): 212-217
DOI: 10.1055/s-0031-1280667
© Thieme Medical Publishers

Chemoembolization with Drug-Eluting Beads Complicated by Intrahepatic Biloma

Michael Naumann1 , Richard Bonsall2 , Ramona Gupta1
  • 1Department of Radiology, Northwestern University, Chicago Illinois
  • 2Forsyth Medical Center Imaging, Winston-Salem, North Carolina
Further Information

Publication History

Publication Date:
16 June 2011 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Chemoembolization with drug-eluting beads is a type of locoregional therapy currently being used for the treatment of hepatocellular carcinoma and metastatic disease to the liver. This treatment has proven effectiveness in controlling tumor growth, extending survival time, and improving quality of life. Chemoembolization with drug-eluting beads have been shown to be safe, but like any other invasive procedure, can have associated complications. The authors present a case of intrahepatic biloma formation occurring as a result of treatment with drug-eluting beads.

KEYWORDS

Biloma - drug-eluting beads - DEBs - chemoembolization

REFERENCES

  • 1 Llovet J M, Beaugrand M. Hepatocellular carcinoma: present status and future prospects.  J Hepatol. 2003;  38 (Suppl 1) S136-S149
    PubMedGoogle Scholar
  • 2 Martin R C, Robbins K, Tomalty D et al.. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.  World J Surg Oncol. 2009;  7 80
    CrossrefPubMedGoogle Scholar
  • 3 Llovet J M, Real M I, Montaña X Barcelona Liver Cancer Group et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.  Lancet. 2002;  359 (9319) 1734-1739
    CrossrefPubMedGoogle Scholar
  • 4 Lo C M, Ngan H, Tso W K et al.. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.  Hepatology. 2002;  35 (5) 1164-1171
    CrossrefPubMedGoogle Scholar
  • 5 Tang Y, Taylor R R, Gonzalez M V, Lewis A L, Stratford P W. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases.  J Control Release. 2006;  116 (2) e55-e56
    CrossrefPubMedGoogle Scholar
  • 6 Taylor R R, Tang Y, Gonzalez M V, Stratford P W, Lewis A L. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.  Eur J Pharm Sci. 2007;  30 (1) 7-14
    CrossrefPubMedGoogle Scholar
  • 7 Aliberti C, Tilli M, Benea G, Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.  Anticancer Res. 2006;  26 (5B) 3793-3795
    PubMedGoogle Scholar
  • 8 Fiorentini G, Aliberti C, Turrisi G et al.. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.  In Vivo. 2007;  21 (6) 1085-1091
    PubMedGoogle Scholar
  • 9 Martin R C, Joshi J, Robbins K, Tomalty D, O'Hara R, Tatum C. Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): multi-institutional registry.  J Oncol. 2009;  2009 539-545
    PubMedGoogle Scholar
  • 10 Lammer J, Malagari K, Vogl T et al. Prospective randomized study of doxorubicin-eluting bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V Study.  Cardiovasc Intervent Radiol. 2010;  33 (1) 41-52
    CrossrefPubMedGoogle Scholar
  • 11 Martin RCG, Howard J, Tomalty D et al.. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.  Cardiovasc Intervent Radiol. 2010;  33 (5) 960-966
    CrossrefPubMedGoogle Scholar
  • 12 Winick A B, Waybill P N, Venbrux A C. Complications of percutaneous transhepatic biliary interventions.  Tech Vasc Interv Radiol. 2001;  4 (3) 200-206
    Google Scholar
  • 13 Dondelinger R F, Kurdziel J C, Gathy C. Percutaneous treatment of pyogenic liver abscess: a critical analysis of results.  Cardiovasc Intervent Radiol. 1990;  13 (3) 174-182
    CrossrefPubMedGoogle Scholar
  • 14 Huang C K, Chen S C, Shih PMC, Chuang W L. Biloma following transcatheter arterial chemoembolization with microspheres: a case report.  Kaohsiung J Med Sci. 2007;  23 (9) 470-474
    CrossrefPubMedGoogle Scholar
  • 15 Touzios J G, Kiely J M, Pitt S C et al.. Neuroendocrine hepatic metastases: does aggressive management improve survival?.  Ann Surg. 2005;  241 (5) 776-783, discussion 783–785
    CrossrefPubMedGoogle Scholar
  • 16 Sakamoto I, Iwanaga S, Nagaoki K et al.. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization.  AJR Am J Roentgenol. 2003;  181 (1) 79-87
    CrossrefPubMedGoogle Scholar
  • 17 Kim H K, Chung Y H, Song B C et al.. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma.  J Clin Gastroenterol. 2001;  32 (5) 423-427
    CrossrefPubMedGoogle Scholar
  • 18 Xia J, Ren Z, Ye S et al.. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.  Eur J Radiol. 2006;  59 (3) 407-412
    CrossrefPubMedGoogle Scholar
  • 19 Akahane M, Koga H, Kato N et al.. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management.  Radiographics. 2005;  25 (Suppl 1) S57-S68
    CrossrefPubMedGoogle Scholar
  • 20 Kemeny N E, Niedzwiecki D, Hollis D R et al.. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).  J Clin Oncol. 2006;  24 (9) 1395-1403
    CrossrefPubMedGoogle Scholar
  • 21 Alazmi W M, McHenry L, Watkins J L et al.. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy.  J Clin Gastroenterol. 2006;  40 (4) 353-357
    CrossrefPubMedGoogle Scholar
  • 22 Shea Jr W J, Demas B E, Goldberg H I, Hohn D C, Ferrell L D, Kerlan R K. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation.  AJR Am J Roentgenol. 1986;  146 (4) 717-721
    PubMedGoogle Scholar
  • 23 Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.  Ann Intern Med. 1987;  107 (4) 459-465
    PubMedGoogle Scholar
  • 24 Minagawa M, Makuuchi M, Torzilli G et al.. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.  Ann Surg. 2000;  231 (4) 487-499
    CrossrefPubMedGoogle Scholar
  • 25 Xia J, Ren Z, Ye S et al.. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.  Eur J Radiol. 2006;  59 (3) 407-412
    CrossrefPubMedGoogle Scholar
  • 26 Kuroda C, Iwasaki M, Tanaka T et al.. Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study.  Radiology. 1983;  149 (1) 85-89
    PubMedGoogle Scholar
  • 27 Shankar S, vanSonnenberg E, Silverman S G, Tuncali K, Morrison P R. Diagnosis and treatment of intrahepatic biloma complicating radiofrequency ablation of hepatic metastases.  AJR Am J Roentgenol. 2003;  181 (2) 475-477
    CrossrefPubMedGoogle Scholar
  • 28 Sicklick J K, Camp M S, Lillemoe K D et al.. Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients.  Ann Surg. 2005;  241 (5) 786-792, discussion 793–795
    CrossrefPubMedGoogle Scholar
  • 29 Atassi B, Bangash A K, Lewandowski R J et al.. Biliary sequelae following radioembolization with Yttrium-90 microspheres.  J Vasc Interv Radiol. 2008;  19 (5) 691-697
    CrossrefPubMedGoogle Scholar
  • 30 Chen M J, Lin C C, Chang W H, Yang F S. Biloma following repeated transcatheter arterial embolization and complicated by intrahepatic duct stones: a case report.  World J Gastroenterol. 2005;  11 (30) 4764-4765
    PubMedGoogle Scholar
  • 31 Kobayashi S, Nakanuma Y, Terada T, Matsui O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus.  Am J Gastroenterol. 1993;  88 (9) 1410-1415
    PubMedGoogle Scholar
  • 32 Miyayama S, Yamashiro M, Okuda M et al.. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma.  Cardiovasc Intervent Radiol. 2010;  33 (6) 1168-1179
    CrossrefPubMedGoogle Scholar
  • 33 Vazquez J L, Thorsen M K, Dodds W J et al.. Evaluation and treatment of intraabdominal bilomas.  AJR Am J Roentgenol. 1985;  144 (5) 933-938
    CrossrefPubMedGoogle Scholar
  • 34 Chen X P, Peng S Y, Peng C H et al.. A ten-year study on non-surgical treatment of postoperative bile leakage.  World J Gastroenterol. 2002;  8 (5) 937-942
    PubMedGoogle Scholar
  • 35 Shankar S, vanSonnenberg E, Silverman S G, Tuncali K, Morrison P R. Diagnosis and treatment of intrahepatic biloma complicating radiofrequency ablation of hepatic metastases.  AJR Am J Roentgenol. 2003;  181 (2) 475-477
    CrossrefPubMedGoogle Scholar
  • 36 Nuñez Jr D, Becerra J L, Martin L C. Subhepatic collections complicating laparoscopic cholecystectomy: percutaneous management.  Abdom Imaging. 1994;  19 (3) 248-250
    CrossrefPubMedGoogle Scholar
  • 37 Sammak B M, Yousef B A, Gali M H, al Karawi M A, Mohamed A E. Case report: radiological and endoscopic management of bile leak following laparoscopic cholecystectomy.  J Gastroenterol Hepatol. 1997;  12 (1) 34-38
    CrossrefPubMedGoogle Scholar
  • 38 Kuligowska E, Schlesinger A, Miller K B, Lee V W, Grosso D. Bilomas: a new approach to the diagnosis and treatment.  Gastrointest Radiol. 1983;  8 (3) 237-243
    CrossrefPubMedGoogle Scholar
  • 39 Walker A T, Shapiro A W, Brooks D C, Braver J M, Tumeh S S. Bile duct disruption and biloma after laparoscopic cholecystectomy: imaging evaluation.  AJR Am J Roentgenol. 1992;  158 (4) 785-789
    PubMedGoogle Scholar
  • 40 Brady P G, Pinkas H, Pencev D. Endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy.  Dig Dis. 1996;  14 (6) 371-381
    CrossrefPubMedGoogle Scholar

Ramona GuptaM.D. 

Department of Radiology, Northwestern University

676 North St. Clair Street, Chicago, IL 60611

Email: gupta.ramona@gmail.com

      >